Likely, agents that induce RPSA endocytosis could have therapeutic potential against Alzheimer's disease and other AD‐related neurodegenerative diseases, such as Prion disease (Sarnataro, 2018; Sarnataro et al., 2016, 2017). The gene discussed is RPSA; the disease is neurodegenerative disease.